FIGURE

Figure 1

ID

ZDB-FIG-230314-27

Publication

Zhou et al., 2023 - The apatinib and pemetrexed combination has antitumor and antiangiogenic effects against NSCLC

Other Figures

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

All Figure Page

Back to All Figure Page

Figure 1

Combination index of apatinib (A) and gemcitabine (B1), paclitaxel (B2), and pemetrexed (B3) in A549 cell line. There are four combination proportions of apatinib and cytotoxic agents (from 1/5 A + 4/5 B to 4/5 A + 1/5 B). The combination index (CI) was used to estimate the combination effects.

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Open Life Sci